These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
706 related articles for article (PubMed ID: 16534614)
1. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2. Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614 [TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of a sulfur-containing heteroarotionoid antitumor agent, SHetA2, using liquid chromatography/tandem mass spectrometry. Liu Z; Zhang Y; Hua YF; Covey JM; Benbrook DM; Chan KK Rapid Commun Mass Spectrom; 2008 Nov; 22(21):3371-81. PubMed ID: 18837006 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration. Ying X; Gao S; Zhu W; Bi Y; Qin F; Li X; Li F J Pharm Biomed Anal; 2007 Jul; 44(3):802-6. PubMed ID: 17459645 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a reverse phase HPLC method for SHetA2, a novel anti-cancer drug, in mouse biological samples. Kukut Hatipoglu M; Mahjabeen S; Garcia-Contreras L J Pharm Biomed Anal; 2019 Jun; 170():124-131. PubMed ID: 30921646 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl. Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study. Yang Z; Liu R; Li X; Tian S; Liu Q; Du G J Pharm Biomed Anal; 2009 Jul; 49(5):1277-81. PubMed ID: 19361943 [TBL] [Abstract][Full Text] [Related]
9. Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice. Sharma A; Li M; Thavathiru E; Ibrahim M; Garcia-Contreras L; Benbrook DM; Woo S AAPS J; 2020 Feb; 22(2):51. PubMed ID: 32086622 [TBL] [Abstract][Full Text] [Related]
10. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics. Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232 [TBL] [Abstract][Full Text] [Related]
11. Highly sensitive analysis of the anti-tumor agent 1-[4-(furo[2,3-b]-quinolin-4-ylamino)phenyl]ethanone in rat plasma by high-performance liquid chromatography using electrochemical detection. Huang YB; Wu PC; Hsu MW; Chen YL; Tzeng CC; Tsai YH J Pharm Biomed Anal; 2005 Jul; 38(3):551-5. PubMed ID: 15925259 [TBL] [Abstract][Full Text] [Related]
12. A rapid and sensitive liquid chromatography-tandem mass spectrometric method for the determination of timosaponin B-II in blood plasma and a study of the pharmacokinetics of saponin in the rat. Cai F; Sun L; Gao S; Yang Y; Yang Q; Chen W J Pharm Biomed Anal; 2008 Dec; 48(5):1411-6. PubMed ID: 19027255 [TBL] [Abstract][Full Text] [Related]
13. Analytical determination and pharmacokinetics of robenacoxib in the dog. Jung M; Lees P; Seewald W; King JN J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454 [TBL] [Abstract][Full Text] [Related]
14. Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs. Kabirov KK; Kapetanovic IM; Benbrook DM; Dinger N; Mankovskaya I; Zakharov A; Detrisac C; Pereira M; Martín-Jiménez T; Onua E; Banerjee A; van Breemen RB; Nikolić D; Chen L; Lyubimov AV Drug Chem Toxicol; 2013 Jul; 36(3):284-95. PubMed ID: 22947079 [TBL] [Abstract][Full Text] [Related]
15. Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method. Jin H; Gerber JP; Wang J; Ji M; Davey AK J Pharm Biomed Anal; 2008 Nov; 48(3):986-90. PubMed ID: 18701231 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. Sharma A; Benbrook DM; Woo S PLoS One; 2018; 13(4):e0194046. PubMed ID: 29634717 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice. Lukka PB; Paxton JW; Kestell P; Baguley BC Cancer Chemother Pharmacol; 2010 May; 65(6):1145-52. PubMed ID: 19774378 [TBL] [Abstract][Full Text] [Related]
18. HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice. Lu W; He LC; Zeng XM J Pharm Biomed Anal; 2008 Jan; 46(1):170-6. PubMed ID: 17889477 [TBL] [Abstract][Full Text] [Related]
19. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Chun KH; Benbrook DM; Berlin KD; Hong WK; Lotan R Cancer Res; 2003 Jul; 63(13):3826-32. PubMed ID: 12839980 [TBL] [Abstract][Full Text] [Related]
20. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection. Wu C; Njar V; Brodie A; Borenstein M; Nnane I J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]